Two minutes. That’s how long visitors spend on XtalPi’s Hit Discovery page.
Effective biotech website design for pharma partnerships is crucial to capturing and keeping their attention.
Not two minutes on the homepage, but on a deep technical service page about AI-powered drug discovery. For context, the average website engagement time across industries hovers around 50 seconds. XtalPi’s core science pages are running at nearly double that, showing the impact of strategic biotech website design in the context of pharma partnerships.
This isn’t a vanity metric. It’s a signal that something important is happening; in particular, well-crafted site design for pharma partnerships in biotech is producing results.
Who actually visits a drug discovery website
XtalPi isn’t selling software subscriptions or SaaS seats. They’re selling multi-year drug discovery partnerships to pharma companies. The people evaluating them are research scientists, BD leads, and C-suite decision makers at companies like Pfizer, Bayer, and Novartis. Successful biotech website design tailored to pharma partnerships helps address all of their needs.
These visitors don’t browse. They evaluate. They land on a Hit Discovery page, and they’re asking specific questions: “What does the platform actually do? How does the AI model interact with wet lab automation? What stage of discovery does this cover? Can I trust the science behind this?”
If your website can’t answer those questions, clearly, credibly, in the right visual language, they close the tab. The evaluation ends before it starts. That’s why implementing the right biotech website design for pharma partnerships is crucial.
When Wizardly built XtalPi’s brand system and interactive website, the goal was engineering for that exact evaluator. 82 design assets over six months. A brand identity that projects credibility to the global pharma market.
An interactive web experience with custom illustrations, charts, and animations that make quantum-physics-meets-laboratory-automation comprehensible to a pharma BD lead.
Engagement depth as a business signal
The XtalPi data doesn’t lie. In 17.5 months post-launch: 325,000 English page views, 1,582 form submissions, 76,759 key conversion events across 154 pages. In biotech, website design that speaks directly to pharma partnership opportunities is a proven driver of these results.
That last number, 154 pages generating conversions, is the one we’re most proud of. It means the content architecture is doing what it was designed to do: guiding visitors from general curiosity through to specific service evaluation to genuine business interest.
Nobody’s doing all the heavy lifting on the homepage alone; it’s the synergy of biotech website design and pharma partnerships that keeps users engaged throughout.
The Publications page runs at a 97.3% engagement rate. The Webinar page at 98.3%. When a scientific audience finds content that matches their level of rigor, they engage fully. When it doesn’t, they leave.
What this means if you sell to scientists
The instinct in B2B design is to simplify everything. Make it cleaner. Reduce the copy. Put the CTA above the fold.
That advice isn’t wrong, but it’s incomplete for scientific audiences. The researchers evaluating your platform want depth. They want to see that you understand the science. A design that strips out the technical detail to make the site feel “cleaner” can actually undermine the credibility you need to win complex partnerships.
The key is effective biotech website design aligned for pharma partnerships to support trust and detail.
The design challenge is making complexity accessible, not making it disappear. That requires understanding the science well enough to illustrate it, and understanding your buyers well enough to know what they need to see before they’ll trust you enough to reach out.
At XtalPi, the result is visitors spending over two minutes on a company overview page. That’s not people who stumbled in. That’s people seriously considering a partnership, and that’s the power of thoughtful biotech website design for meaningful pharma partnerships.
👉 See the full XtalPi case study → View the XtalPi project →
